Real-world clinical outcomes of patients with BRAF-mutated melanoma with or without brain metastases receiving frontline immune-checkpoint inhibitors in the US community oncology setting.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Comprehensive Cancer Centers of Nevada
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4410818499
